Advisor Group’s Ocera Therapeutics OCRX Stock Holding History
Bought
Maintained
Sold
Advisor Group's OCRX Position: Q4 2017 in Review
Advisor Group sold out of Ocera Therapeutics (OCRX) in Q4 2017, closing a stake of 1,200 shares — an estimated $1K sold.
Advisor Group first reported a position in OCRX in Q1 2017 and held it in 3 quarters. The position peaked at $1K in Q3 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.
- Advisor Group reported no remaining Ocera Therapeutics position as of Q4 2017 after selling out during the quarter.
- Advisor Group sold 1,200 Ocera Therapeutics shares in Q4 2017, an estimated $1K.
- Advisor Group first reported a position in Ocera Therapeutics in Q1 2017 and held it in 3 quarters.
- Advisor Group's Ocera Therapeutics position peaked at $1K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q4 2017.
Based on Advisor Group's 13F filing for Q4 2017, filed 14 Feb 2018.